Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metagenomi (MGX) EPS (Basic) (2023 - 2025)

Historic EPS (Basic) for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to -$0.55.

  • Metagenomi's EPS (Basic) fell 784.31% to -$0.55 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4, marking a year-over-year increase of 6866.84%. This contributed to the annual value of -$2.36 for FY2024, which is 8821.25% up from last year.
  • As of Q3 2025, Metagenomi's EPS (Basic) stood at -$0.55, which was down 784.31% from -$0.54 recorded in Q2 2025.
  • Metagenomi's EPS (Basic)'s 5-year high stood at -$0.29 during Q2 2024, with a 5-year trough of -$5.82 in Q3 2023.
  • Over the past 3 years, Metagenomi's median EPS (Basic) value was -$0.71 (recorded in 2024), while the average stood at -$2.23.
  • As far as peak fluctuations go, Metagenomi's EPS (Basic) soared by 9240.84% in 2024, and later tumbled by 8620.69% in 2025.
  • Over the past 3 years, Metagenomi's EPS (Basic) (Quarter) stood at -$5.67 in 2023, then surged by 87.51% to -$0.71 in 2024, then increased by 22.36% to -$0.55 in 2025.
  • Its EPS (Basic) was -$0.55 in Q3 2025, compared to -$0.54 in Q2 2025 and -$0.68 in Q1 2025.